Reaction
Acquired Factor V Deficiency reporting signals
As of the last recalculation, Acquired Factor V Deficiency appears in 110 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is UMECLIDINIUM (PRR 395.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Umeclidinium | 16 | 395.4 | 396.2 |
| Ampicillin | 13 | 336.7 | 337.2 |
| Ampicillin Sodium | 13 | 336.7 | 337.2 |
| Budesonide | 47 | 262.8 | 263.0 |
| Tobramycin Solution | 14 | 252.5 | 252.8 |
| Tobramycin Sulfate | 14 | 245.0 | 245.3 |
| Omalizumab | 49 | 195.4 | 195.5 |
| Adrenalinum | 27 | 162.8 | 162.9 |
| Apixaban | 37 | 157.2 | 157.2 |
| Ceftriaxone | 20 | 140.7 | 140.8 |
| Ceftriaxone Sodium | 22 | 135.4 | 135.5 |
| Mepolizumab | 26 | 129.3 | 129.4 |
| Tobramycin | 14 | 126.1 | 126.1 |
| Umeclidinium Bromide And Vilanterol Trifenatate | 8 | 97.6 | 97.7 |